Literature DB >> 2417752

Laboratory tests in the differential diagnosis of hyperamylasemia.

N W Tietz, W Y Huang, D F Rauh, D F Shuey.   

Abstract

We evaluated the clinical utility of some recently developed laboratory methods, including total amylase by three methods; isoamylase by inhibition and isoelectric focusing; lipase by pH-Stat and turbidimetry; and immunoreactive trypsin. All methods correlated highly positively with hyperamylasemia due to primary acute pancreatitis. Pancreatic-type isoamylase determinations have the greatest clinical usefulness, because total amylase, lipase, and immunoreactive trypsin are increased in a relatively high percentage of other abdominal diseases. Increases in the last-mentioned enzymes in nonpancreatic abdominal disease may be the result of injuries to the pancreas secondary to the primary disease, which are being detected with these highly sensitive methods. Because of the high clinical sensitivity of lipase and immunoreactive trypsin determinations, a normal result tends to exclude acute pancreatitis. Hyperamylasemia seen in lung carcinoma is due to increase in an amylase isoenzyme similar to the salivary-type amylase. The method for pancreatic-type isoamylase based on selective inhibition is satisfactory for routine clinical laboratory use.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417752

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use.

Authors:  Po-Chun Chang; Joni A Cirelli; Qiming Jin; Yang-Jo Seol; James V Sugai; Nisha J D'Silva; Theodora E Danciu; Lois A Chandler; Barbara A Sosnowski; William V Giannobile
Journal:  Hum Gene Ther       Date:  2009-05       Impact factor: 5.695

2.  Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes.

Authors:  P Malfertheiner; M Büchler; A Stanescu; W Uhl; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1987-06

3.  Sarcoidosis and the pancreas.

Authors:  P A McCormick; M O'Donnell; K McGeeney; O FitzGerald; D A McCormick; M X FitzGerald
Journal:  Ir J Med Sci       Date:  1988-06       Impact factor: 1.568

4.  Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis.

Authors:  Xiang-Yu Kong; Yi-Qi Du; Lei Li; Jian-Qiang Liu; Guo-Kun Wang; Jia-Qi Zhu; Xiao-Hua Man; Yan-Fang Gong; Li-Ning Xiao; Yong-Zhi Zheng; Shang-Xin Deng; Jun-Jun Gu; Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

5.  Correlation and prognostic significance of serum amylase, serum lipase, and plasma cholinesterase in acute organophosphorus poisoning.

Authors:  Ajit Dungdung; Abhinav Kumar; Bindey Kumar; Mukul Preetam; Ruth K Tara; Md K Saba
Journal:  J Family Med Prim Care       Date:  2020-04-30

Review 6.  Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.

Authors:  Gianluca Rompianesi; Angus Hann; Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

7.  Histopathologic correlates of serum amylase activity in acute experimental pancreatitis.

Authors:  J Schmidt; K Lewandrowski; C Fernandez-del Castillo; U Mandavilli; C C Compton; A L Warshaw; D W Rattner
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

8.  Prognostic significance of various biochemical parameters in acute organophosphorus poisoning.

Authors:  M E Sumathi; S Harish Kumar; K N Shashidhar; Nandini Takkalaki
Journal:  Toxicol Int       Date:  2014-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.